Manulife Financial Q3 2026 earnings

MFC · 2026-11-04 17:07 AMC ET · 6-K on SEC

Record core EPS and 17.8% core ROE driven by double-digit growth in Asia and North American insurance, offset by lower GAAP net income and Global WAM outflows.

Headline numbers

not stated in the 6-K

Revenue breakdown

SegmentActualYoYShare of revenueNote
Asia$1.2B+17%57%Strong business growth, improved claims experience, net positive impact of actuarial updates
Global WAM$100M-5%5%Higher net fee income offset by eMPF transition, workforce expenses, and lower performance fees
Canada$600M+3%29%More favourable claims experience in Individual Insurance and higher Manulife Bank earnings
U.S.$200M+5%9%Favourable life insurance claims experience and business growth
Corporate and Other-$55M0 pp-3%Non-recurrence of 3Q25 withholding tax adjustment and lower earnings on surplus assets

Margins and costs

  • Gross margin N/A
  • Operating expenses N/A
  • One-offs in the quarter Net charge from Vietnam operations ($0.4B); Net charge from market experience ($0.4B); Increased ECL provisions; Annual actuarial review impact ($128M pre-tax)
  • Effective tax rate N/A
  • Non-GAAP bridge Core earnings excludes amortization of intangible assets acquired in business combinations (software and distribution agreements excluded from 3Q25 onwards) and includes net positive impact of actuarial method updates.

KPIs

MetricActualPrior quarterPrior yearChange
CSM$27,318M$27,263M$23,969M+$55M
NBV margin35.3%36.3%36.3%-1.0 pp
Expense efficiency ratio44.5%44.5%44.5%0 pp

Guidance

not stated in the 6-K

What drove it

  • Revenue story Core earnings grew 4% YoY driven by strong business growth in Asia and the U.S., higher revenues in Global WAM, and improved insurance experience.
  • EPS story Core EPS increased 6% YoY driven by core earnings growth and improved insurance experience.
  • One-off check Net charge from Vietnam operations ($0.4B) and net charge from market experience ($0.4B).

The good

  • Record core EPS ($1.24)
  • Core ROE of 17.8%
  • Double-digit core earnings growth in Asia (+17%)

The bad

  • GAAP EPS down 21% YoY ($0.82)
  • Global WAM net outflows ($3.6B)
  • Lower than expected returns on alternative long-duration assets

The ugly

  • none

Open questions

  • Impact of the eMPF transition in Hong Kong on Global WAM and Asia core earnings
  • Drivers of lower than expected returns on alternative long-duration assets (private equity, real estate, farmland)
  • Reason for lower GAAP EPS despite core EPS growth
Full release

Manulife Financial (MFC) earnings release, November 4, 2026

Manulife Financial Corp (MFC) · Form 6-K · Filed · SEC filing

1

Manulife Reports

Third Quarter 2026 Results

TSX/NYSE/PSE: MFC SEHK: 945

C$ unless otherwise stated

TORONTO, ON – November 4, 2026 – Manulife Financial Corporation (“Manulife” or the “Company”) reported its third quarter results for the period ended

September 30, 2026, delivering record core earnings¹ and continued strong momentum in Asia.

Key highlights for the third quarter of 2026

(“

3Q26”) include:

• Core earnings of

$2.1 billion, up

4% on a CER basis² compared with the third quarter of 2025

(“

3Q25”)

• Net income attributed to shareholder s of

$1.4 billion, down

$0.4 billion from

3Q25

• Core EPS³ of

$1.24, up

6%² from

3Q25.

EPS of

$0.82, down

21%² from

3Q25

• Core ROE³ of

17.8% and ROE of

11.8%

• LICAT ratio⁴ of

136%

• APE sales⁵, new business CSM² and new business value (“NBV”)⁵ were broadly in line with

3Q25

• Global Wealth and Asset Management (“Global WAM”) net outflows⁵ of

$3.6 billion, compared with

$6.2 billion of net outflows in

3Q25

“We delivered strong third quarter results, achieving record core EPS and

17.8% core ROE, driven by double- digit core earnings growth in Asia and meaningful contributions from our North American insurance businesses.

These results reflect the disciplined execution of the strategy we launched a year ago and our ability to deliver sustained growth in an uncertain environment.”

“

During the quarter, we expanded customer choice through enhanced investment and protection offerings, completed Manulife | Comvest’s largest fundraise in the history of Comvest's private credit platform, scaled AI- enabled capabilities that are delivering measurable outcomes for customers and advisors, and advanced new health and longevity solutions and partnerships. Together, these actions are strengthening our competitive position, deepening customer relationships, and creating long-term value for shareholders.” — Phil Witherington, Manulife President & Chief Executive Officer

“We remained disciplined in our capital deployment during the quarter, returning $1.3 billion to shareholders while maintaining a strong balance sheet, with a LICAT ratio of

136% and a financial leverage ratio³ below our medium-term target. In addition, we completed our annual review of actuarial methods and assumptions, resulting in a net favourable impact and reinforcing the robustness of our reserves.”

“As we continue to invest in growth across our businesses, we also further improved our expense efficiency during the quarter. Our financial flexibility and consistent execution position us well to sustain long-term value creation.” — Colin Simpson, Manulife Chief Financial Officer²

Results at a Glance

Results by Segment³

Strategic Highlights

We are expanding customer access to wealth solutions through product enhancements and expansion

In Canada, we expanded our segregated fund lineup by adding eight new funds and broadened access to eleven existing funds. The enhanced suite increases investment choice and flexibility for customers and advisors, helping

Canadians diversify their portfolios, build long-term wealth, and pursue their evolving financial goals.

In Global WAM, we raised

US$5.4 billion of capital through the close of Comvest Credit Partners VII. This marked

Manulife | Comvest’s largest fundraise in the history of Comvest’s private credit platform⁶, attracting commitments from both existing and new institutional investors and expanding the platform’s global investor relationships.

In the U.S., we broadened our ability to meet a wider range of customer protection and long-term planning needs through enhancements to our indexed universal life and survivorship indexed universal life solutions, and the introduction of three differentiated term life insurance solutions. Together, these enhancements and new offerings expand our protection portfolio and provide financial professionals with greater choice and flexibility to address evolving customer needs.

We are scaling and advancing solutions as an AI-powered organization while further enhancing

AI governance and responsible use

We expanded our strategic partnership with Microsoft through a new five-year agreement. The agreement includes extending Microsoft 365 Copilot to more than 30,000 employees to further enable productivity and innovation, as well as deploying Microsoft Agent 365 to strengthen enterprise AI governance and drive AI solutions at enterprise scale.

In Asia, we continued to extend proven AI-enabled advisory capabilities into new markets, bringing these capabilities to the Chinese Mainland and Malaysia to help agents analyze customer and family coverage, identify protection gaps across life, health, and investment goals, recognize life-event triggers, and prepare for customer meetings. In Malaysia, the tool also generates personalized talking points, including needs-based analysis questions, and recommends next steps linked to customers' financial planning goals.

In Global WAM, we completed the rollout of an AI-enabled advisor engagement platform to all external wholesalers and investment specialists across North America Retail, identifying four times more product opportunities and capturing richer advisor insights. The platform also improved productivity through automated documentation, reducing meeting administration and follow-up activities, saving approximately 30 minutes per session.

In the U.S., we scaled our Quick Quote underwriting support tool to automate more than 70% of preliminary assessments, up from nearly 50% in the first quarter of 2026, rapidly expanding our proven AI-enabled underwriting capability to reduce average turnaround time and optimize our utilization of underwriting expertise.

We are advancing our health and longevity leadership through innovative strategic partnerships, expanded wellness offerings and simpler access to healthcare

In Asia, we signed a Memorandum of Understanding (“MOU”) with

Ant Health⁷, setting out a collaboration framework covering health management services, cross-boundary healthcare support, digital health capabilities and insurance technology. In October, we launched the first initiative under the MOU, offering cashless direct billing through Alipay for eligible customers at participating healthcare providers in the Chinese Mainland, making healthcare access easier.

In Canada, we began offering AI-enabled virtual physiotherapy in partnership with Sword®, a global AI health company, to eligible Group Benefits members on disability with musculoskeletal conditions. This initiative helps address barriers to care through convenient, personalized support from licensed Canadian clinicians while supporting faster recovery and return-to-work outcomes.

In the U.S., we strengthened our leadership in longevity and differentiated behavioural insurance by expanding the health and wellness offerings available through John Hancock Vitality, including Prenuvo’s advanced heart health scan and ŌURA’s latest smart ring, providing customers access to additional tools and insights to help them live longer, healthier, better lives.⁴

Continued business growth drove record core earnings⁸

Core earnings of

$2.1 billion in

3Q26, up

4% from

3Q25

The increase in core earnings reflected strong business growth in Asia and the U.S., higher revenues in Global

WAM, improved insurance experience, and the net positive impact of 3Q26 updates to actuarial methods and assumptions, p artially offset b y increased expected credit loss (“ECL”) provisions and the impact of the eMPF transition in Hong Kong.

• Asia core earnings increased

17%, reflecting continued business growth, the net positive impact of 3Q²⁶ updates to actuarial methods and assumptions, improved impact of new business and improved claims experience, partially offset by increased ECL provisions.

• Global WAM core earnings decreased

5%, as higher net fee income from favourable market impacts over the past 12 months and contributions from the Manulife | Comvest business were more than offset by the impact of the eMPF transition in Hong Kong, higher workforce-related expenses and investment in business growth, favourable tax true-ups in 3Q25, and lower performance fees.

• Canada core earnings increased

3%, reflecting more favourable claims experience in Individual Insurance, higher Manulife Bank earnings and higher investment spreads, partially offset by unfavourable claims experience in Group Insurance and increased ECL provisions.

• U.S. core earnings increased

5%, reflecting favourable life insurance claims experience, including net positive impacts from the 3Q

26 updates to actuarial methods and assumptions, business growth and favourable tax items, partially offset by increased ECL provisions and unfavourable lapse experience.

• Corporate and Other core earnings decreased by

$55 million, driven by the non-recurrence of a 3Q25 withholding tax adjustment and lower earnings on surplus assets, partially offset by favourable tax-related true- ups.

Net income attributed to shareholders of

$1.4 billion in

3Q26,

$0.4 billion lower compared with

3Q25

The $0.4 billion decrease in net income was driven by a larger net charge on market experience and a net charge from our Vietnam operations⁹, partially offset by core earnings growth. The net charge from market experience in

3Q26 reflected lower than expected returns on alternative long-duration assets, mainly related to private equity, real estate, and farmland investments, as well as lower than expected returns on public equities and losses from derivatives and hedge accounting ineffectiveness.

Resilient new business results highlight the benefits of our diversified business model

APE sales, new business CSM and NBV were broadly in line with the prior year

• Asia delivered strong s ales growth in Hong Kong and Japan, offset by lower sales in the Chinese Mainland.

APE sales, new business CSM and NBV were broadly in line with 3Q25.

NBV margin was

35.3%.⁵

• In Canada, APE sales increased

3% and

NBV was in line with 3Q25, largely driven by higher Individual

Insurance sales, partially offset by lower Group Insurance sales. New business CSM increased

5%, reflecting higher sales volumes in Individual Insurance and higher margins in Annuities, partially offset by lower margins in Individual Insurance.

• U.S. APE sales were in line with

3Q25, while changes in product mix resulted in a decrease in new business

CSM and NBV of

20% and

13%, respectively.

Global WAM net outflows of $

3.6 billion in

3Q26, compared with net outflows of $

6.2 billion in

3Q25

• Retirement net outflows were

$4.9 billion in

3Q26 compared with net outflows of

$1.6 billion in

3Q25.

The variance is attributable to higher retirement plan redemptions in the U.S., higher net member withdrawals reflecting higher account balances from market growth across all regions, and lower new plan sales in

Canada.

• Retail net flows were neutral in

3Q26 compared with net outflows of

$3.9 billion in

3Q25.

The variance is primarily driven by higher net flows through our retail wealth business and third-party intermediaries in

Canada, and higher net flows in the Chinese Mainland, partially offset by lower net flows through third-party intermediaries in the U.S.

• Institutional Asset Management net inflows were

$1.4 billion in

3Q26 compared with net outflows of

$0.7 billion in

3Q25.

The variance reflects higher net flows from fixed income mandates, private credit mandates in the

Manulife | Comvest business, equity and infrastructure mandates, partially offset by lower net flows from... (truncated) Mainland and from Manulife | CQS products.⁵

New business growth continued to drive positive organic

CSM movement and a higher CSM balance

CSM¹⁰ was

$27,318 million as at

September 30, 2026

CSM increased

$2,349 million compared with

December 31, 2025. Organic CSM movement contributed

$1,622 million of the increase, representing a

9% annualized growth in our CSM net of NCI balance¹¹, primarily driven by the impact of new business, interest accretion, and net favourable insurance experience, partially offset by amortization recognized in core earnings.

Inorganic

CSM movement was an increase of

$727 million, driven by the favourable impacts of changes in foreign currency exchange rates, partially offset by the net unfavourable impact of markets.

Post-tax CSM net of NCI¹ was

$22,701 million as at

September 30, 2026.

Annual review of actuarial methods and assumptions

We completed our annual review of actuarial methods and assumptions, which resulted in a net favourable impact of a

$128 million¹² decrease in pre-tax fulfilment cash flows. Under International Financial Reporting Standards (as issued by the International Accounting Standards Board) (“IFRS”) 17, the impact of the annual review of actuarial methods and assumptions is reported in several places. The

$128 million decrease in pre-tax fulfilment cash flows was comprised of a decrease in pre-tax net income attributed to shareholders of

$217 million

(

$175 million post- tax), a decrease in pre-tax net income attributed to participating policyholders of

$4 million

(

$3 million post-tax), an increase in CSM of

$47 million, an increase in pre-tax other comprehensive income attributed to shareholders of

$306 million

(

$240 million post-tax), and a decrease in pre-tax other comprehensive income attributed to participating policyholders of

$4 million

(

$2 million post-tax).

The actuarial review this year included valuation model enhancements and assumption updates for U.S. life insurance riders, morbidity and mortality assumptions in Vietnam, valuation model updates for participating products in Asia, lapse assumptions for investment-linked products in Singapore, mortality assumptions in our U.S. life insurance business, and other methodology refinements.

(1)

Core earnings and post-tax contractual service margin (“CSM”) net of non-controlling interests (“NCI”)

(“post-tax CSM net of NCI”) are non-GAAP financial measures.

For more information on non-GAAP and other financial measures, see

“Non-GAAP and other financial measures” below and in our

3Q26

Management’s Discussion and Analysis (“

3Q26

MD&A”).

(2)

Percentage growth/declines in core earnings, diluted core earnings per common share (“core EPS”), diluted earnings (loss) per share (“EPS”), new business

CSM, and net income attributed to shareholders are stated on a constant exchange rate (“CER”) basis and are non-GAAP ratios.

(3)

Core EPS, core return on common shareholders’ equity (“ROE”), expense efficiency ratio, adjusted book value per common share, financial leverage ratio, and core earnings before interest, taxes, depreciation and amortization (“EBITDA”) margin are non-GAAP ratios.

(4)

Life Insurance Capital Adequacy Test (“LICAT”) ratio of The Manufacturers Life Insurance Company (“MLI”) as at

September 30, 2026. LICAT ratio is disclosed under the Office of the Superintendent of Financial Institutions LICAT Public Disclosure Requirements guideline.

(5)

For more information on annualized premium equivalent (“APE”) sales, NBV, net flows, gross flows, average assets under management and administration

(“average AUMA”) and new business value margin (“NBV margin”), see

“Non-GAAP and other financial measures” below. In this news release, percentage growth/decline in

APE sales, NBV, net flows, gross flows, and average AUMA are stated on a constant exchange rate basis.

(6)

The largest fundraise in the history of Comvest Credit Partners, including prior to its combination with Manulife.

(7)

AHA Healthcare Technology HK Limited.

(8)

See section A1 “Profitability” in our

3Q26

MD&A for more information on notable items attributable to core earnings and net income attributed to shareholders.

(9)

Reflects a net charge from a partial impairment of a bancassurance asset and a gain on the sale of a Vietnam insurance subsidiary.

(10)

CSM net of NCI.

(11)

Percentage growth / decline in our CSM net of NCI balance from organic CSM movement is stated on a constant exchange rate basis and is a non-GAAP ratio.

This percentage is calculated as the annualized year-to-date change in organic CSM net of NCI divided by the December 31, 2025 CSM net of NCI balance.

(12)

This amount excludes the portion related to NCI.⁶

Earnings Results Conference Call

Manulife will host a conference call and live webcast on its

Third Quarter 2026 results on November 5, 2026, at

8:00 a.m. (ET). To access the conference call, dial

1-888-317-6003 or

1-647-846-2809

(Passcode: 0306024

#).

Please call in 15 minutes before the scheduled start time. You will be required to provide your name and organization to the operator. You may access the webcast at https://www.manulife.com/ca/en/about-us/investors/ results-and-reports.

The archived webcast will be available following the call at the same URL as above. A replay of the call will also be available until February 5, 2027, by dialing

1-855-669-9658 or

1-412-317-0088

(Passcode: 8612393

#).

The

Third Quarter 2026

Statistical Information Package is also available on the Manulife website at https:// www.manulife.com/ca/en/about-us/investors/results-and-reports.

This earnings news release should be read in conjunction with the Company’s

Third Quarter 2026

Report to

Shareholders, including our unaudited interim Consolidated Financial Statements for the three and nine months ended

September 30, 2026... (truncated) IFRS, which is available on our website at https:// www.manulife.com/ca/en/about-us/investors/results-and-reports. The Company’s

3Q26

MD&A and additional information relating to the Company is available on the SEDAR+ website at https://www.sedarplus.ca and on the

U.S. Securities and Exchange Commission’s (“SEC”) website at https://www.sec.gov.

Any information contained in, or otherwise accessible through, websites mentioned in this news release does not form a part of this document unless it is expressly incorporated by reference.⁷

Earnings

The following table presents net income attributed to shareholders, consisting of core earnings and details of the items excluded from core earnings:

Non-GAAP and other financial measures

The Company prepares its Consolidated Financial Statements in accordance with IFRS. We use a number of non-

GAAP and other financial measures to evaluate overall performance and to assess each of our businesses. This section includes information required by National Instrument 52-112 – Non-GAAP and other Financial Measures

Disclosure in respect of “specified financial measures” (as defined therein).

Non-GAAP financial measures include core earnings (loss); core earnings available to common shareholders; core earnings before interest, taxes, depreciation and amortization (“core EBITDA”); core expenses; adjusted book value; post-tax contractual service margin; post-tax contractual service margin net of NCI (“post-tax CSM net of

NCI”); and core revenue. In addition, non-GAAP financial measures include the following stated on a constant exchange rate (“CER”) basis: any of the foregoing non-GAAP financial measures; net income attributed to shareholders; common shareholders’ net income; CSM; CSM net of NCI and new business CSM.

Non-GAAP ratios include core return on common shareholders’ equity (“core ROE”); diluted core earnings per common share (“core EPS”); expense efficiency ratio; adjusted book value per common share; financial leverage ratio; core EBITDA margin; growth in the CSM net of NCI from organic CSM movement; and percentage growth/ decline on a CER basis in any of the above non-GAAP financial measures and non-GAAP ratios; net income attributed to shareholders; diluted earnings per common share (“EPS”); CSM; CSM net of NCI; and new business

CSM.

Other specified financial measures include NBV; APE sales; gross flows; net flows; average assets under management and administration (“average AUMA”); NBV margin; and percentage growth/decline in these foregoing specified financial measures. In addition, explanations of the components of the CSM movement, other than new business CSM are provided in our

3Q26

MD&A.

Non-GAAP financial measures and non-GAAP ratios are not standardized financial measures under GAAP and, therefore, might not be comparable to similar financial measures disclosed by other issuers. Therefore, they should not be considered in isolation or as a substitute for any other financial information prepared in accordance with GAAP. For more information on non-GAAP financial measures, including those referred to above, see the section “Non-GAAP and other financial measures” in our

3Q26

MD&A, which is incorporated by reference.⁸

Reconciliation of core earnings to net income attributed to shareholders – 3Q26

($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)

Core earnings, CER basis and U.S. dollars – 3Q26

($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)

(1)

The impact of updating foreign exchange rates to that which was used in

3Q26.

(2)

Income tax on core earnings adjusted to reflect the foreign exchange rates for the Statement of Income in effect for

3Q26.

(3)

Core earnings (post-tax) in Canadian $ are translated to US $ using the US $ Statement of Income exchange rate for

3Q26.⁹

Reconciliation of core earnings to net income attributed to shareholders – 2Q26

($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)

Core earnings, CER basis and U.S. dollars – 2Q26

($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)

(1)

The impact of updating foreign exchange rates to that which was used in

3Q26.

(2)

Income tax on core earnings adjusted to reflect the foreign exchange rates for the Statement of Income in effect for

3Q26.

(3)

Core earnings (post-tax) in Canadian $ are translated to US $ using the US $ Statement of Income exchange rate for

2Q26.¹⁰

Reconciliation of core earnings to net income attributed to shareholders – 3Q25

($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)

Core earnings, CER basis and U.S. dollars – 3Q25

($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)

(1)

The impact of updating foreign exchange rates to that which was used in

3Q26.

(2)

Income tax on core earnings adjusted to reflect the foreign exchange rates for the Statement of Income in effect for

3Q26.

(3)

Core earnings (post-tax) in Canadian $ are translated to US $ using the US $ Statement of Income exchange rate for

3Q25.¹¹

Reconciliation of core earnings to net income attributed to shareholders – YTD

2026

($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)

Core earnings, CER basis and U.S. dollars – YTD

2026

($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)

(1)... (truncated)d in

3Q26.

(2)

Income tax on core earnings adjusted to reflect the foreign exchange rates for the Statement of Income in effect for

3Q26.

(3)

Core earnings (post-tax) in Canadian $ are translated to US $ using the US $ Statement of Income exchange rate for the respective quarters that make up

2026 year-to-date core earnings.¹²

Reconciliation of core earnings to net income attributed to shareholders – YTD

2025

($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)

Core earnings, CER basis and U.S. dollars – YTD

2025

($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)

(1)

The impact of updating foreign exchange rates to that which was used in

3Q26.

(2)

Income tax on core earnings adjusted to reflect the foreign exchange rates for the Statement of Income in effect for

3Q26.

(3)

Core earnings (post-tax) in Canadian $ are translated to US $ using the US $ Statement of Income exchange rate for the respective quarters that make up

2025 year-to-date core earnings.

Core earnings available to common shareholders

($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)

(1)

The impact of updating foreign exchange rates to that which was used in

3Q26.¹³

Core ROE

($ millions, unless otherwise stated)

CSM and post-tax CSM information

($ millions pre-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)

(1)

The impact of reflecting CSM and CSM net of NCI using the foreign exchange rates for the Statement of Financial Position in effect for

3Q26.¹⁴

New business CSM

(1) detail, CER basis

($ millions pre-tax, and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)

(1)

New business CSM is net of NCI.

(2)

Other includes Cambodia, Indonesia, International High Net Worth, Malaysia, Myanmar, the Philippines and Vietnam.

(3)

The impact of updating foreign exchange rates to that which was used in

3Q26.¹⁵

Net income financial measures on a CER basis

($ Canadian millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)

(1)

The impact of updating foreign exchange rates to that which was used in

3Q26.

(2)

Asia net income attributed to shareholders (post-tax) in Canadian dollars is translated to U.S. dollars using the U.S. dollar Statement of Income rate for the respective reporting period.

Adjusted book value

($ millions)¹⁶

Reconciliation of Global WAM core earnings to core EBITDA

($ millions, pre-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)

(1)

The impact of updating foreign exchange rates to that which was used in

3Q26.

Core EBITDA margin and core revenue

($ millions, unless otherwise stated)¹⁷

Core expenses

($ millions, and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)

(1)

Expenses are components of insurance service expenses on the Statements of Income that flow directly through income.

(2)

The impact of updating foreign exchange rates to that which was used in

3Q26.¹⁸

CAUTION REGARDING FORWARD-LOOKING STATEMENTS

From time to time, Manulife makes written and/or oral forward-looking statements, including in this document. In addition, our representatives may make forward-looking statements orally to analysts, investors, the media and others. All such statements are made pursuant to the “safe harbour” provisions of Canadian provincial securities laws and the U.S.

Private Securities Litigation Reform Act of 1995.

The forward-looking statements in this document include, but are not limited to, statements with respect to our ability to achieve our medium-term financial and operating targets, and the expected benefits and value derived from the use of AI and also relate to, among other things, our objectives, goals, strategies, intentions, plans, beliefs, expectations and estimates, and can generally be identified by the use of words such as “may”, “will”, “could”, “should”, “would”, “likely”,

“suspect”, “outlook”, “expect”, “intend”, “estimate”, “anticipate”, “believe”, “plan”, “forecast”, “objective”, “seek”, “aim”,

“continue”, “goal”, “restore”, “embark” and “endeavour” (or the negative thereof) and words and expressions of similar import, and include statements concerning possible or assumed future results. Although we believe that the expectations reflected in such forward-looking statements are reasonable, such statements involve risks and uncertainties, and undue reliance should not be placed on such statements and they should not be interpreted as confirming market or analysts’ expectations in any way.

Certain material factors or assumptions are applied in making forward-looking statements and actual results may differ materially from those expressed or implied in such statements.

Important factors that could cause actual results to differ materially from expectations include but are not limited to: general business and economic conditions (including but not limited to the performance, volatility and correlation of equity markets, interest rates, credit and swap spreads, inflation rates, currency rates, investment losses and defaults, market liquidity and creditworthiness of guarantors, reinsurers and counterparties); changes in laws and regulations; changes in accounting standards applicable in any of the territories in which we operate; changes in regulatory capital requirements; our ability to obtain premium rate increases on in-force policies; our ability to execute strategic plans and changes to... (truncated)ur ability to maintain our reputation; impairments of goodwill or intangible assets or the establishment of provisions against future tax assets; the accuracy of estimates relating to morbidity, mortality and policyholder behaviour; the accuracy of other estimates used in applying accounting policies and actuarial methods and embedded value methods; our ability to implement effective hedging strategies and unforeseen consequences arising from such strategies; our ability to source appropriate assets to back our long-dated liabilities; level of competition and consolidation; our ability to market and distribute products through current and future distribution channels; unforeseen liabilities or asset impairments arising from acquisitions and dispositions of businesses; the realization of losses arising from the sale of investments classified fair value through other comprehensive income; our liquidity, including the availability of financing to satisfy existing financial liabilities on expected maturity dates when required; obligations to pledge additional collateral; the availability of letters of credit to provide capital management flexibility; accuracy of information received from counterparties and the ability of counterparties to meet their obligations; the availability, affordability and adequacy of reinsurance; legal and regulatory proceedings, including tax audits, tax litigation or similar proceedings; our ability to adapt products and services to the changing market; our ability to attract and retain key executives, employees and agents; the appropriate use and interpretation of complex models or deficiencies in models used; political, legal, operational and other risks associated with our operations; geopolitical uncertainty, including international conflicts and trade disputes; acquisitions and our ability to complete acquisitions including the availability of equity and debt financing for this purpose; the disruption of or changes to key elements of the Company’s or public infrastructure systems; environmental concerns, including climate change; our ability to protect our intellectual property and exposure to claims of infringement; our ability to execute our digital plans and to deploy future digital use cases, including with respect to AI, and our inability to withdraw cash from subsidiaries.

Additional information about material risk factors that could cause actual results to differ materially from expectations and about material factors or assumptions applied in making forward-looking statements may be found under “Risk

Management and Risk Factors” and “Critical Actuarial and Accounting Policies” in the Management’s Discussion and

Analysis in our most recent annual report, under “Risk Management and Risk Factors Update” and “Critical Actuarial and

Accounting Policies” in the Management’s Discussion and Analysis in our most recent interim report, and in the “Risk

Management” note to the Consolidated Financial Statements in our most recent annual and interim reports, as well as elsewhere in our filings with Canadian and U.S. securities regulators.

The forward-looking statements in this document are, unless otherwise indicated, stated as of the date hereof and are presented for the purpose of assisting investors and others in understanding our financial position and results of operations, our future operations, as well as our objectives and strategic priorities, and may not be appropriate for other purposes. We do not undertake to update any forward-looking statements, except as required by law.

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · Manulife Financial earnings · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.